Recent News and Articles on the Keywords: cancer + colorectal + response  Related to the article below (Last Update: 12/1/2008)

 News results: Standard Version | Text Version | Image Version Results 1 - 10 of about 102 for cancer colorectal response. (0.24 seconds) 
Recent
Archives
  • All dates
  • 2007
  • 2006
  • 2005
  • 2004
  • 1999-2003

 Sorted by relevance   Sort by date   Sort by date with duplicates included 
An At-Home Cancer Test
ToTheCenter.com, NY - Nov 28, 2008
However, colorectal cancer is often asymptomatic in the earliest stages and, therefore, not caught in time. In response to these statistics, ...
Merck Serono: European Commission Approves Erbitux For 1st-Line ...
Medical News Today (press release), UK -
It has been approved for the treatment of colorectal cancer in 75 countries so far: Argentina, Australia, Belarus, Canada, Chile, China, Colombia, ...
Sirtex's SIR-Spheres(R) Microspheres Featured on Sky Radio's ...
MarketWatch - Nov 24, 2008
Of the nearly 150000 Americans diagnosed with colorectal cancer every year, at least 60 percent will see their cancer spread to the liver. ...ASX:SRX
Pioneering Research Led by JWCI Scientists Improves Accuracy of ...
Business Wire (press release), CA - Nov 25, 2008
The study, ?Prognostic Relevance of Occult Nodal Micrometastases and Circulating Tumor Cells in Colorectal Cancer in a Prospective Multicenter Trial,? was ...
Gene Test Could Predict Colon Cancer's Return U.S. News & World Report
all 17 news articles »
KRAS Gene Testing Included in NCCN Guidelines for Colon Cancer
Medscape - Nov 25, 2008
Testing colorectal tumors for EGFR has shown no predictive value regarding the likelihood of response to cetuximab or panitumumab therapy. ...
Recent research on cancer-fighting diets
The Plain Dealer - cleveland.com, OH - Nov 25, 2008
The highest risk is for prostate, colorectal and breast cancer. Researchers at the University of California, San Diego School of Medicine have shown how ...
Avastin Plus Commonly Used Chemotherapies Demonstrated Improved ...
WELT ONLINE, Germany - Nov 23, 2008
Avastin was the first anti-angiogenesis therapy approved by the FDA and is approved to treat metastatic colorectal cancer, advanced non-squamous, ...DNA
$6 Million Bets Ginseng Will Cure Colon Cancer
HealthNews, CA - Nov 11, 2008
Their research center, called the Center for Herbal Research on Colorectal Cancer, will delve into ginseng?s anti-tumor effects through lab and animal ...

HealthNews
Breast Cancer Drug Avastin Meets Latest Study Goals
HealthNews, CA - Nov 25, 2008
Avastin is also approved for use in advanced colorectal, lung and kidney cancer. To date, Avastin has been used to treat more than 350000 cancer patients. ...
Studies of DNA Methylation in Cancer Beginning to Yield Clinical ...
Journal of American Medical Association (subscription), IL - Nov 11, 2008
In July, Laboratory Corporation of America Holdings began offering a noninvasive stool DNA test for colorectal cancer based on this research. ...
Source: Google News


 

Recent News and Articles on the Keywords: cancer + colorectal + aggressive  Related to the article below (Last Update: 8/5/2008)


Boston Globe
Patience Might Have Paid Off
New York Times, United States - Jul 31, 2008
Erbitux is now approved as a treatment for head and neck cancer and as a last-ditch treatment for colorectal cancer. But ImClone and Bristol hope to win ...
ImClone Holders Underwhelmed By Bid, But In Icahn They Trust CNNMoney.com
all 764 news articles »  IMCL

Enews 2.0
FDA Approves New Test for Aggressive Breast Cancer
Enews 2.0, UK - Jul 9, 2008
Among men, the three most commonly diagnosed cancers are prostate, lung and colorectal cancer in developed countries and lung, stomach and liver cancer in ...
Let?s get personal
Malaysia Star, Malaysia - Jul 26, 2008
Predictive biomarkers are useful not only in breast cancer. In colorectal cancer (cancer of the large intestine), we have the K-RAS oncogene. ...
Low Socioeconomic Status Increases Cancer Mortality
Cancer Consultants, ID - Jul 24, 2008
Researchers from Emory University have recently reported that the declines in death rates from lung, breast, prostate, and colorectal cancer in persons ...
'Smothered' Genes Combine With Mutations To Yield Poor Outcome In ...
Science Daily (press release) - Jul 15, 2008
After reviewing samples from 30 breast and 20 colorectal cancer patients as well as information from public microarray databases, the researchers found 18 ...
New cancer scanner at QEII
TheChronicleHerald.ca, Canada - Jul 17, 2008
The PET/CT scanner isn?t meant to do the initial diagnosis of diseases like breast or colorectal cancer but can be used later to assess the effectiveness of ...
Belly up to better health - trim midsection fat
The Desert Sun, CA - Jul 31, 2008
Last year, a panel of cancer experts concluded that there is convincing evidence that excess abdominal fat is a cause of colorectal cancer and probably a ...
Einstein Researchers ID Gene Pattern Linked to 5-FU Response in ...
Pharmacogenomics Reporter (subscription), NY - Jul 16, 2008
By Turna Ray Scientists at the Albert Einstein College of Medicine of Yeshiva University have accurately predicted whether colorectal cancer tumors are ...
A Biotech Bloom in July
Seeking Alpha, NY - Jul 28, 2008
Imclone?s (IMCL) cancer drug Erbitux received approval in Japan on July 16th for use in advanced colorectal cancer. With this approval, Eribtux is the first ...
Molecular detection (k-ras) of exfoliated tumour cells in the ...
7thSpace Interactive (press release), NY - Jul 27, 2008
... by denaturing capillary electrophoresis with respect to mutations in hotspots of the k-ras gene, which are frequently mutated in colorectal cancer. ...
Source: Google News

… -dependent degradation of the cyclin-dependent kinase inhibitor p 27 in aggressive colorectal -
M Loda, B Cukor, SW Tam, P Lavin, M Fiorentinc, GF … - Nature Medicine, 1997 - nature.com
... is thus a powerful negative prognostic marker in colorectal carcinomas, particularly ...
These data suggest that aggressive tumors may result from the ... Cancer Res. ...

… of international criteria for the determination of microsatellite instability in colorectal cancer -
CR Boland - Cancer Research, 1998 - AACR
... Instability and RER Phenotypes in Cancer Detection and ... MSI-H colorectal tumors are
found predominantly in ... are associated with a less aggressive clinical course ...

Local recurrence of colorectal cancer: effect of early detection and aggressive surgery. -
R Schiessel, M Wunderlich, F Herbst - Br J Surg, 1986 - ncbi.nlm.nih.gov
Br J Surg. 1986 May;73(5):342-4. Local recurrence of colorectal cancer:
effect of early detection and aggressive surgery. Schiessel ...

Initial Presentation With Stage IV Colorectal Cancer: How Aggressive Should We Be? -
SA Rosen, JF Buell, A Yoshida, S Kazsuba, R Hurst, … - Archives of Surgery, 2000 - archsurg.highwire.org
... Initial Presentation With Stage IV Colorectal Cancer How Aggressive Should
We Be? Seth A. Rosen, MD ; Joseph F. Buell, MD ; Atsushi ...
-

Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant Chemotherapy. -
H Bismuth, R Adam, F L?vi, C Farabos, F Waechter, … - Annals of Surgery, 1996 - annalsofsurgery.com
... improved in selected patients the poor prognosis of previously unresectable liver
metastases from colorectal cancer. An aggressive surgical approach in these ...

Colorectal cancer screening: Clinical guidelines and rationale -
SJ Winawer, RH Fletcher, L Miller, F Godlee, MH … - Gastroenterology, 1997 - Elsevier
... Adenomatous Polyposis tient deal with the high lifetime risk of colorectal cancer
and other cancers and the need for aggressive screening. Because ...

… for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer: Analysis of 1001 … -
Y Fong, J Fortner, RL Sun, MF Brennan, LH Blumgart - Annals of Surgery, 1999 - annalsofsurgery.com
... of the patient with metastatic colorectal cancer, and more ... that resection of hepatic
colorectal metastases represents ... An ever-more-aggressive approach is being ...

… Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer -
VJ Verwaal, S van Ruth, E de Bree, GW van Slooten, … - Journal of Clinical Oncology, 2003 - jcojournal.org
... 25 Recently, somewhat more aggressive schedules of combination chemotherapy have
been introduced in advanced colorectal cancer, which may be associated with a ...

p53 point mutation and survival in colorectal cancer patients -
HS Goh - Cancer Research, 1995 - AACR
... of the p53 tumor suppressor gene and survival in colorectal cancer patients ... domains
of the p53 tumor suppressor gene were inherently more aggressive than tumors ...

Hereditary Nonpolyposis Colorectal Cancer and Colonic Adenomas: Aggressive Aden om as? -
HT LYNCH, R JASS - Seminars in Surgical Oncology, 1995 - doi.wiley.com
... Hereditary nonpolyposis colorectal cancer (HNPCC) results from an ... is the precursor
to colorectal carcinoma in the ... in support of the ?Aggressive Adenoma? in ...

Source: Google Scholar
 

   
   

Aggressive Immune Response Helps Colorectal Cancer Patients

European researchers have discovered one of the reasons why some colorectal cancers are more aggressive and likely to spread than others.

The reason is that in some people, the body's immune system mounts an effective defense against the tumor and against the tumor's attempt to spread to other sites in the body.

The anti-tumor cells generated by the immune system are called "effector memory T cells."

"Effector memory T cells have the capacity to recognize and kill tumor cells. These cells, located in the tumor, have a long-lasting anti-tumor activity, persist within the body and destroy distant tumor cells," said one of the study's authors, Jerome Galon, a research scientist at the French National Institute of Health and Medical Research in Paris.

Results of the study appear in the Dec. 22 issue of the New England Journal of Medicine.

More than 140,000 new cases of colorectal cancer are diagnosed each year in the United States, according to the American Cancer Society (ACS). The disease is responsible for about 56,000 deaths each year, making it the nation's second-leading cause of cancer death, according to the ACS.

Because little is known about how the immune system responds when cancers begin to spread, Galon and his colleagues analyzed the immune response to colorectal cancer tumor samples from 959 people.

The researchers looked for evidence of early metastasis, or spreading, of the cancer. Early signs of metastasis include blood vessel blockages, invasion of the lymphatic system and infiltration of the nerves. Together, the researchers collectively referred to these signs as VELIPI. VELIPI-positive cancers were those that were already spreading to other sites throughout the body.

After identifying each tumor as VELIPI-positive (257) or VELIPI-negative (702), the researchers then compared the groups to see if there were any differences.

There were. People with VELIPI-negative tumors were more likely to have a higher density of effector memory T cells, and they were more likely to live longer. On average, those with VELIPI-negative tumors lived 35 months, compared to 16.3 months for those with VELIPI-positive tumors.

"Effector memory T cells have a major impact on colorectal cancer evolution. These cells prevent tumor dissemination within the body and distant metastasis, and improve survival of the patients," said Galon.

Galon said these T cells kill tumor cells that attempt to migrate from the original tumor.

"The immune system, under appropriate conditions, may be effective in controlling or limiting cancer spread if the appropriate number and quality of immune cells can be mobilized by the first tumor site," said Dr. Giorgio Parmiani, chairman of the unit of immunotherapy of human tumors and the department of innovative therapies at Istituto Nazionale Tumori in Milan, Italy. Parmiani wrote an accompanying editorial in the same issue of the journal.

Galon said these findings could eventually help classify and "stage" tumors, giving doctors a better way to predict the course a cancer might take. In the long-term, he added, these findings could help lead to the development of an immunotherapy that could boost the immune response, especially that of the effector memory T cells, to more effectively fight colorectal cancer.

More information

To learn more about colon cancer, visit the American Gastroenterological Association.

Health Tip: Teen Years Can Be Tough

December 21, 2005 08:41:54 PM PST

Teens have a lot to deal with, including school, sports, friendships and changing hormones.

Sometimes, it's hard to understand why you are in a bad mood and can't seem to snap out of it.

Here are some suggestions that could make your bad mood easier to handle, courtesy of the Nemours Foundation:

  • Recognize that you're not alone.
  • Count to 10 and catch your breath.
  • Talk to people you trust.
  • Exercise.
  • Get enough sleep.
  • Get involved in creative projects, such as writing, drawing or other forms of art.
  • Cry.
  • Wait it out.

If your bad mood isn't subsiding and is interfering with schoolwork or daily activities, talk to a counselor, your parents or a therapist.

Health Tip: Floss for Good Tooth Health

December 21, 2005 08:41:54 PM PST

Most people know it's important to floss every day, but many don't know the proper technique. The American Dental Association offers these tips:
  • Break off about 18 inches of floss and wind most of it around both middle fingers. Hold the floss between your thumbs and forefingers.
  • Using a rubbing motion, guide the floss between your teeth.
  • When the floss reaches the gum line, curve it into a C shape against one tooth and slide it into the space between the gum and the tooth.
  • Hold the floss tightly against the tooth. Gently rub the side of the tooth, moving the floss away from the gum with up and down motions.
  • Repeat throughout your whole mouth.

 

Continue with:

H2

H3

H4

H5

H6

H7

H8

H9

H9A

 

 © 2002-2006

Keywords:

Contact Iconocast

Home Page